Breast cancer, version 1.2016 featured updates to the NCCN guidelines

William J. Gradishar; Benjamin O. Anderson; Ron Balassanian; Sarah L. Blair; Harold J. Burstein; Amy Cyr; Anthony D. Elias; William B. Farrar; Andres Forero; Sharon Hermes Giordano; Matthew Goetz; Lori J. Goldstein; Clifford A. Hudis; Steven J. Isakoff; P. Kelly Marcom; Ingrid A. Mayer; Beryl McCormick; Meena Moran; Sameer A. Patel; Lori J. Pierce; Elizabeth C. Reed; Kilian E. Salerno; Lee S. Schwartzberg; Karen Lisa Smith; Mary Lou Smith; Hatem Soliman; George Somlo; Melinda Telli; John H. Ward; Dottie A. Shead; Rashmi Kumar

doi:10.6004/jnccn.2015.0176

Breast cancer, version 1.2016 featured updates to the NCCN guidelines

William J. Gradishar, Benjamin O. Anderson, Ron Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Matthew Goetz, Lori J. Goldstein, Clifford A. Hudis, Steven J. Isakoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Meena Moran, Sameer A. Patel, Lori J. PierceElizabeth C. Reed, Kilian E. Salerno, Lee S. Schwartzberg, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda Telli, John H. Ward, Dottie A. Shead, Rashmi Kumar

Health Services Research

Research output: Contribution to journal › Article › peer-review

134 Scopus citations

Abstract

These NCCN Guideline Insights highlight the important updates to the systemic therapy recommendations in the 2016 NCCN Guidelines for Breast Cancer. In the most recent version of these guidelines, the NCCN Breast Cancer Panel included a new section on the principles of preoperative systemic therapy. In addition, based on new evidence, the panel updated systemic therapy recommendations for women with hormone receptor-positive breast cancer in the adjuvant and metastatic disease settings and for patients with HER2-positive metastatic breast cancer. This report summarizes these recent updates and discusses the rationale behind them.

Original language	English (US)
Pages (from-to)	1475-1485
Number of pages	11
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	13
Issue number	12
DOIs	https://doi.org/10.6004/jnccn.2015.0176
State	Published - Dec 1 2015

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2015.0176

Cite this

Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., Goetz, M., Goldstein, L. J., Hudis, C. A., Isakoff, S. J., Marcom, P. K., Mayer, I. A., McCormick, B., Moran, M., Patel, S. A., ... Kumar, R. (2015). Breast cancer, version 1.2016 featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 13(12), 1475-1485. https://doi.org/10.6004/jnccn.2015.0176

Gradishar, WJ, Anderson, BO, Balassanian, R, Blair, SL, Burstein, HJ, Cyr, A, Elias, AD, Farrar, WB, Forero, A, Giordano, SH, Goetz, M, Goldstein, LJ, Hudis, CA, Isakoff, SJ, Marcom, PK, Mayer, IA, McCormick, B, Moran, M, Patel, SA, Pierce, LJ, Reed, EC, Salerno, KE, Schwartzberg, LS, Smith, KL, Smith, ML, Soliman, H, Somlo, G, Telli, M, Ward, JH, Shead, DA & Kumar, R 2015, 'Breast cancer, version 1.2016 featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 13, no. 12, pp. 1475-1485. https://doi.org/10.6004/jnccn.2015.0176

@article{f516bdff948f4cb287d8a0c2e7c68738,

title = "Breast cancer, version 1.2016 featured updates to the NCCN guidelines",

abstract = "These NCCN Guideline Insights highlight the important updates to the systemic therapy recommendations in the 2016 NCCN Guidelines for Breast Cancer. In the most recent version of these guidelines, the NCCN Breast Cancer Panel included a new section on the principles of preoperative systemic therapy. In addition, based on new evidence, the panel updated systemic therapy recommendations for women with hormone receptor-positive breast cancer in the adjuvant and metastatic disease settings and for patients with HER2-positive metastatic breast cancer. This report summarizes these recent updates and discusses the rationale behind them.",

author = "Gradishar, {William J.} and Anderson, {Benjamin O.} and Ron Balassanian and Blair, {Sarah L.} and Burstein, {Harold J.} and Amy Cyr and Elias, {Anthony D.} and Farrar, {William B.} and Andres Forero and Giordano, {Sharon Hermes} and Matthew Goetz and Goldstein, {Lori J.} and Hudis, {Clifford A.} and Isakoff, {Steven J.} and Marcom, {P. Kelly} and Mayer, {Ingrid A.} and Beryl McCormick and Meena Moran and Patel, {Sameer A.} and Pierce, {Lori J.} and Reed, {Elizabeth C.} and Salerno, {Kilian E.} and Schwartzberg, {Lee S.} and Smith, {Karen Lisa} and Smith, {Mary Lou} and Hatem Soliman and George Somlo and Melinda Telli and Ward, {John H.} and Shead, {Dottie A.} and Rashmi Kumar",

year = "2015",

month = dec,

day = "1",

doi = "10.6004/jnccn.2015.0176",

language = "English (US)",

volume = "13",

pages = "1475--1485",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "12",

}

TY - JOUR

T1 - Breast cancer, version 1.2016 featured updates to the NCCN guidelines

AU - Gradishar, William J.

AU - Anderson, Benjamin O.

AU - Balassanian, Ron

AU - Blair, Sarah L.

AU - Burstein, Harold J.

AU - Cyr, Amy

AU - Elias, Anthony D.

AU - Farrar, William B.

AU - Forero, Andres

AU - Giordano, Sharon Hermes

AU - Goetz, Matthew

AU - Goldstein, Lori J.

AU - Hudis, Clifford A.

AU - Isakoff, Steven J.

AU - Marcom, P. Kelly

AU - Mayer, Ingrid A.

AU - McCormick, Beryl

AU - Moran, Meena

AU - Patel, Sameer A.

AU - Pierce, Lori J.

AU - Reed, Elizabeth C.

AU - Salerno, Kilian E.

AU - Schwartzberg, Lee S.

AU - Smith, Karen Lisa

AU - Smith, Mary Lou

AU - Soliman, Hatem

AU - Somlo, George

AU - Telli, Melinda

AU - Ward, John H.

AU - Shead, Dottie A.

AU - Kumar, Rashmi

PY - 2015/12/1

Y1 - 2015/12/1

N2 - These NCCN Guideline Insights highlight the important updates to the systemic therapy recommendations in the 2016 NCCN Guidelines for Breast Cancer. In the most recent version of these guidelines, the NCCN Breast Cancer Panel included a new section on the principles of preoperative systemic therapy. In addition, based on new evidence, the panel updated systemic therapy recommendations for women with hormone receptor-positive breast cancer in the adjuvant and metastatic disease settings and for patients with HER2-positive metastatic breast cancer. This report summarizes these recent updates and discusses the rationale behind them.

AB - These NCCN Guideline Insights highlight the important updates to the systemic therapy recommendations in the 2016 NCCN Guidelines for Breast Cancer. In the most recent version of these guidelines, the NCCN Breast Cancer Panel included a new section on the principles of preoperative systemic therapy. In addition, based on new evidence, the panel updated systemic therapy recommendations for women with hormone receptor-positive breast cancer in the adjuvant and metastatic disease settings and for patients with HER2-positive metastatic breast cancer. This report summarizes these recent updates and discusses the rationale behind them.

UR - http://www.scopus.com/inward/record.url?scp=84951105908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951105908&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2015.0176

DO - 10.6004/jnccn.2015.0176

M3 - Article

C2 - 26656517

AN - SCOPUS:84951105908

SN - 1540-1405

VL - 13

SP - 1475

EP - 1485

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 12

ER -

Breast cancer, version 1.2016 featured updates to the NCCN guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this